Algo version: 0.98b
BristolMyers Squibb is listed at the SIX Exchange
BristolMyers Squibb [BMY.SW]
SIX Sector: Healthcare Industry:Medical Pharmaceuticals

Is BristolMyers Squibb stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, BristolMyers Squibb pays dividends. Last time was Monday 3rd of June 2024 where the investors holding the stock on Monday 6th of May 2024 were paid $0.44112 per share. Over the last 32 times between 2014 and 2024, BristolMyers Squibb has paid $13.62488 with an average of $0.43 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for BristolMyers Squibb 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $44.39, you would have made a profit of $9.85 per share or 22.19%

We do not have enough data to give you this answer.

BristolMyers Squibb has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.24, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for BristolMyers Squibb to be high [0.75 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.